Exhibit 23.2

 

 

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-259476 and File No. 333-275965) and the Registration Statement on Form S-3 (File No. 333-266890 and File No. 333-273221) our report dated March 28, 2024 relating to the consolidated financial statements of Unicycive Therapeutics, Inc. appearing in this Annual Report (Form 10-K) as of and for the year ended December 31, 2023.

 

/s/ GRASSI & CO., CPAs, P.C.  
GRASSI & CO., CPAs, P.C.  
Jericho, New York  
March 28, 2024